Risk of Gastric Cancer Among Patients With Intestinal Metaplasia of the Stomach in a United States Integrated Healthcare System.Reddy KM, Chang JI, Shi JM, Wu BU. Clin Gastroenterol Hepatol. 2016 Jun 15. [Epub ahead of print]
BACKGROUND & AIMS:Gastric intestinal metaplasia (GIM) is a common finding from routine endoscopies. Although GIM is an early step in gastric carcinogenesis, there is controversy over routine surveillance in of patients with GIM in regions with a low prevalence gastric cancer.
We aimed to determine the incidence of gastric cancer among patients with GIM and risk factors for gastric cancer.METHODS:We performed a retrospective cohort study of patients diagnosed with GIM from 2000 through 2011, collected from the Kaiser Permanente Southern California region. GIM was identified by a keyword search of pathology reports; gastric cancer cases were identified by cross-reference with an internal cancer registry. The incidence of gastric cancer in patients with GIM (n=923; median age at diagnosis, 68 years) was compared with that of an age- and sex-matched reference population (controls). Risk factors such as ethnicity, smoking status, history of Helicobacter pylori infection, and family history of gastric cancer were evaluated by individual Cox proportional hazards regression. We then performed a second case-cohort study to evaluate the risk of gastric cancer based on location and extent of GIM. The median duration of follow-up was 4.6 years (interquartile range [IQR], 3.0-6.7 years).RESULTS:We identified 25 patients with GIM that developed gastric cancers. Seventeen cases of cancer were diagnosed at the same time as the diagnosis of GIM. Eight cases of cancer were identified within a median time period of 4.6 years after a diagnosis of GIM (IQR, 2-5.7 years). The overall incidence rate for the cohort was 1.72 (95% CI, 0.74-3.39). Among the risk factors evaluated, only family history (hazard ratio, 3.8; 95% CI, 1.5-9.7; P=.012) and extent of GIM (odds ratio, 9.4; 95% CI, 1.8-50.4) increased the risk for gastric cancer. The incidence rate for gastric cancer in those with a positive family history was 8.12 (95% CI, 0.1.67-23.73).CONCLUSION:In an analysis of patients with GIM listed in the Kaiser Permanente Southern California database, 2.7% were diagnosed with gastric cancer; almost 70% cases of gastric cancer were detected at the time of GIM diagnosis. Family history and extensive metaplasia were associated with increased risk of subsequent gastric cancer. Targeted surveillance of patients with these criteria could increase early detection of gastric cancer.


